0001209191-22-054328.txt : 20221021
0001209191-22-054328.hdr.sgml : 20221021
20221021190338
ACCESSION NUMBER: 0001209191-22-054328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221019
FILED AS OF DATE: 20221021
DATE AS OF CHANGE: 20221021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wills Robert James
CENTRAL INDEX KEY: 0001634189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38899
FILM NUMBER: 221324608
MAIL ADDRESS:
STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR
CITY: MEMPHIS
STATE: TN
ZIP: 38103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001408443
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
BUSINESS PHONE: (514) 336-0444
MAIL ADDRESS:
STREET 1: 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
CITY: MONTREAL
STATE: A8
ZIP: H4M 2X6
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-19
0
0001408443
Milestone Pharmaceuticals Inc.
MIST
0001634189
Wills Robert James
C/O MILESTONE PHARMACEUTICALS INC.
1111 DR. FREDERIK-PHILIPS BLVD, STE 420
MONTREAL
A8
H4M 2X6
QUEBEC, CANADA
1
0
0
0
Common Shares
2022-10-19
4
P
0
15000
4.93
A
15000
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.89 to $4.9494 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Jason Minio, Attorney-in-Fact
2022-10-21